Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholecystokinin modulates mucosal immunoglobulin A function

J Alverdy1, E Stern, S Poticha

  • 1Department of Surgery and Hematopathology, University of Chicago, IL 60637, USA.

Surgery
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalizing nutrition therapy in inflammatory bowel disease: Practical applications and review of the latest studies.

Current opinion in pharmacology·2026
Same author

Differential cognitive, neurophysiological, and stress responses to acute cycling and stretching in young adults with risky alcohol use.

Pharmacology, biochemistry, and behavior·2026
Same author

Some New Lanoline Ointments.

Buffalo medical and surgical journal·2023
Same author

Quantitative SPECT/CT parameters of myocardial <sup>99m</sup>Technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis.

EJNMMI research·2021
Same author

Systematic review: methodological flaws in racial/ethnic reporting for gastroesophageal reflux disease.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2018
Same author

Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same journal

One-year health care expenditures and patient out-of-pocket spending after open versus minimally invasive hepatopancreatobiliary surgery.

Surgery·2026
Same journal

Shock index, hypotension, and blood product transfusion as predictors of post-traumatic stress disorder in firearm-related trauma.

Surgery·2026
Same journal

Outcomes following endovascular aortic aneurysm repair in nonagenarian patients.

Surgery·2026
Same journal

Fistulotomy with primary sphincteroplasty for complex anal fistulas: Should we be concerned about incontinence?

Surgery·2026
Same journal

No need for mesh in the repair of hiatal hernias: Autologous tissue hiatoplasty techniques for the repair of the complex diaphragmatic defect.

Surgery·2026
Same journal

Incretin-based therapies and altered myocardial metabolism in a swine model of ischemic heart disease in the setting of metabolic syndrome.

Surgery·2026
See all related articles

Glucocorticoids suppress mucosal immunity, but cholecystokinin (CCK) administration can restore immunoglobulin A (IgA) production and immune function in rats. This highlights CCK

Area of Science:

  • Immunology
  • Gastroenterology
  • Endocrinology

Background:

  • Mucosal immunoglobulin A (IgA) production is critically dependent on cholecystokinin (CCK) release.
  • Glucocorticoids are known to significantly suppress mucosal IgA production.
  • The interplay between CCK, glucocorticoids, and mucosal immunity requires further investigation.

Purpose of the Study:

  • To investigate the role of cholecystokinin in maintaining mucosal IgA system function.
  • To assess the impact of CCK on glucocorticoid-impaired mucosal immunity in rats.

Main Methods:

  • Fischer rats were administered vehicle, dexamethasone (DEX), or DEX plus a CCK agonist (ARL1294KF).
  • Duodenal CCK levels, ileal mucosal IgA, cecal bacterial adherence, and mucosal electrical resistance were measured.

Related Experiment Videos

  • Radioimmunoassay, cell quantification, bacterial culture, and Ussing chamber techniques were employed.

    • Main Results:

    • Dexamethasone significantly decreased duodenal CCK, reduced IgA levels, and impaired mucosal immunity.
    • Impaired immunity manifested as increased bacterial adherence and decreased tissue resistance.
    • CCK agonist administration preserved mucosal immune function in DEX-treated rats.

    Conclusions:

    • Cholecystokinin plays a crucial role in preserving mucosal immune function.
    • CCK may be vital for maintaining mucosal immunity during catabolic stress.
    • Targeting CCK pathways could offer therapeutic strategies for immune dysfunction.